Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Catasys Launches OnTrak™ Facebook Page

Catasys Health - Monday, January 04, 2010
Check out our new Catasys Health Facebook Recovery Network http://www.facebook.com/stayontrak. Also, don't forget to Like our Facebook Health Care Page.

Social Media Philosophy - Lead the social media revolution in Substance Dependence and Behavioral Health Care, contributing to health and well being for families and friends everywhere.

 » More


Cutting Edge Treatment for Substance Dependence for Health Plans

Catasys Health - Wednesday, December 16, 2009
For every 1 million members in a health plan, approximately $160 million in claims are incurred by members diagnosed with Substance Dependence. Most health plans have realistic cost savings opportunities in the millions of dollars. Our Medical Economics group can demonstrate specific savings opportunities for health plans with respect to both medical and behavioral costs.

The OnTrak program addresses many of the challenges experts highlight within the existing treatment paradigm for substance dependence. Specifically, OnTrak» More

Changing the Paradigm of Substance Dependent Treatment

Catasys Health - Wednesday, December 02, 2009

How OnTrak is Different - We function as a provider in your network and your MBHO’s network, complementing your existing delivery system. We go much deeper than your current programs to address the uniquely difficult needs of your high-utilizing substance dependent members. » More



Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 » More



Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced:
 » More



Catasys Launches OnTrak Member Website

Catasys Health - Tuesday, September 02, 2008

Welcome to OnTrak, a unique treatment program for substance dependence that is covered under your health benefits. We guide you step by step through the transition from substance dependence to sobriety: a process known as recovery. » More





| 1 |

 

 
  Tags
 
placebo drug abuse sugar drug use oxycodone flumazenil recovery opioid antagonist hospitalizations withdrawal placebo-controlled meth opiod abuse morphine smoking UnitedHealthcare SD health insurance addiction treatment fentanyl reducing craving behavioral healthcare services urine drug screen SD members medical costs substance dependence costs contract Journal of Psychopharmacology alcohol drinking nicotine trauma gabapentin dependence issues naloxone opioid abuse behavioral health care services drug addicts care coaching craving score addiction treatment post-traumatic stress disorder Opioid Medications marijuana randomized prometa drug addiction Health Care Utilization medical and behavioral costs methamphetamine double-blind Research Across America alcohol treatment Co Occurring Disorders cigarettes hydrocodone Raymond Anton cocaine Catasys sober facebook PTSD depression screening binge drinking behavioral health craving sobriety opioid drinking alcoholism opioid overdose ADHD medical ER psychosocial high-utilizing overdose opiates diabetes alcohol pain medication relapse prevention social network chronic pain opioid-drug interactions percocet stimulants substance use disorder Opioid Treatment substance dependence behavioral healthcare narcotic methamphetamine dependence ADD muscle relaxant pain pills mental health alcohol dependence data mining heroin hospital relapse CIWA opiod-based OxyContin emergency room substance dependence health insurance stress buprenorphine OnTrak primary care vicodin mental illness physician- patient relations behavioral health care communication stratified vivitrol health reform codeine anxiety suboxone over-the-counter substances reduction in craving health insurance Harold Urschel health plan drug treatment methadone recovery network painkillers bipolar disorder identification cocaine treatment depression pain killers predictive modeling reduction in use prescriptions addict
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025